EGFR-TKI-based vs non-EGFR-TKI-based adjuvant therapy in resected non-small-cell lung cancer with EGFR mutations: a meta-analysis of randomized controlled trials

OncoTargets and Therapy ◽

10.2147/ott.s174593 ◽

2018 ◽

Vol Volume 11 ◽

pp. 6803-6810 ◽

Author(s):

Jing-Xun Wu ◽

Qi He ◽

Feng Ye ◽

Qing-Xia Zhou ◽

Hao-Jun Chen ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Therapy ◽

Small Cell Lung Cancer ◽

Meta Analysis ◽

Egfr Mutations ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled ◽

Download Full-text

EGFR tyrosine kinase inhibitors alone or in combination with chemotherapy for non-small-cell lung cancer with EGFR mutations: A meta-analysis of randomized controlled trials

Journal of Cancer Research and Therapeutics ◽

10.4103/jcrt.jcrt_195_20 ◽

2021 ◽

Vol 17 (3) ◽

pp. 664

Author(s):

Qing-Shan Li ◽

Cui-Min Zhu ◽

Xiang-Yao Lian ◽

Hong-Yan Zhang ◽

Lu Bai ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Egfr Mutations ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled ◽

Egfr Tyrosine Kinase Inhibitors

Download Full-text

Role of pemetrexed in advanced non-small-cell lung cancer: meta-analysis of randomized controlled trials, with histology subgroup analysis

Current Oncology ◽

10.3747//co.19.891 ◽

2012 ◽

Vol 19 (1) ◽

Author(s):

K. Alsaleh ◽

C. Quinton ◽

P. M. Ellis

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Subgroup Analysis ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

The benefits and risks of CTLA4 inhibitor plus PD1/PDL1 inhibitor in stage IIIB/IV non‐small cell lung cancer: A systematic analysis and meta‐analysis based on randomized controlled trials

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13465 ◽

2021 ◽

Author(s):

Qiangyun Liu ◽

Zige Fang ◽

Miaowen Liu ◽

Ruoxin Xu ◽

Fengming Yi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Systematic Analysis ◽

Randomized Controlled

Download Full-text

Effectiveness of neoadjuvant chemotherapy on the survival outcomes of patients with resectable non-small-cell lung cancer: A meta-analysis of randomized controlled trials

Surgical Oncology ◽

10.1016/j.suronc.2021.101590 ◽

2021 ◽

pp. 101590

Author(s):

Yunfeng Zhang ◽

Xiayun Hu ◽

Dapeng Liu ◽

Rui Wang ◽

Xin Sun ◽

...

Keyword(s):

Lung Cancer ◽

Neoadjuvant Chemotherapy ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Survival Outcomes ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

Risk profile of bevacizumab in patients with non-small cell lung cancer: A meta-analysis of randomized controlled trials

Acta Oncologica ◽

10.3109/0284186x.2011.631579 ◽

2011 ◽

Vol 51 (2) ◽

pp. 151-156 ◽

Author(s):

Chao Cao ◽

Jianmiao Wang ◽

Hansvin Bunjhoo ◽

Yongjian Xu ◽

Huijuan Fang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Risk Profile ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase III randomized controlled trials

OncoTargets and Therapy ◽

10.2147/ott.s85648 ◽

2015 ◽

pp. 2023 ◽

Author(s):

Xuan He ◽

Yuanming Li ◽

Ji Wang

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Phase Iii ◽

Controlled Trials ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

Systematic review and meta-analysis of third-line salvage therapy for the treatment of advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials

10.18632/oncotarget.24967 ◽

2018 ◽

Vol 9 (83) ◽

pp. 35439-35447

Author(s):

Nan Zhang ◽

Nan Guo ◽

Liang Tian ◽

Zhigang Miao

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Salvage Therapy ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled ◽

Download Full-text

A Meta-Analysis of the Efficacy and Toxicity of Twice-Daily vs. Once-Daily Concurrent Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer Based on Randomized Controlled Trials

Frontiers in Oncology ◽

10.3389/fonc.2019.01460 ◽

2020 ◽

Vol 9 ◽

Author(s):

Qian Wu ◽

Yiting Xiong ◽

Shujuan Zhang ◽

Xinling Chen ◽

Fengming Yi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Concurrent Chemoradiotherapy ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled

Download Full-text

Efficacy and safety of pembrolizumab for treating advanced non-small-cell lung cancer: a meta-analysis of phase II and III randomized controlled trials

Journal of Chemotherapy ◽

10.1080/1120009x.2021.2014714 ◽

2021 ◽

pp. 1-9

Author(s):

Tianyao Gong ◽

Lei Liu ◽

Yufei Liu ◽

Ke Liu ◽

Yang Yang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Randomized Controlled ◽

Phase Ii And Iii

Download Full-text

The Impact of Afatinib on Survival in Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

Journal of Cancer ◽

10.7150/jca.27528 ◽

2019 ◽

Vol 10 (4) ◽

pp. 885-892

Author(s):

Chi Wang ◽

Yun Li ◽

Li Ke ◽

Lejie Cao ◽

Pingsheng Fan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Controlled Trials ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Controlled Trials ◽

Small Cell Lung ◽

Randomized Controlled ◽

Download Full-text